Using Kifunensine to Crystallize CTLA-4 Protein
Author Information
Author(s): Yu Chao, Crispin Max, Sonnen Andreas F.-P., Harvey David J., Chang Veronica T., Evans Edward J., Scanlan Christopher N., Stuart David I., Gilbert Robert J. C., Davis Simon J.
Primary Institution: Nuffield Department of Clinical Medicine, University of Oxford
Hypothesis
Can kifunensine effectively inhibit glycan processing in long-term cultures of CHO cells to facilitate the crystallization of CTLA-4?
Conclusion
Kifunensine allows for the successful crystallization of the CTLA-4 homodimer by inhibiting glycan processing in long-term cultures.
Supporting Evidence
- The use of kifunensine allowed for the production of CTLA-4 homodimer in long-term cultures.
- Crystallization of the CTLA-4 homodimer was achieved with high-quality crystals.
- Analysis showed that kifunensine effectively restricted glycan processing to specific structures.
Takeaway
Researchers found that a special chemical called kifunensine helps make a protein called CTLA-4 easier to study by allowing it to form crystals, which is important for understanding how it works.
Methodology
The study involved using kifunensine in long-term cultures of CHO cells to inhibit glycan processing, followed by protein purification and crystallization techniques.
Limitations
The study did not directly examine the effect of kifunensine on the levels of expression of CTLA-4ex.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website